Psykogen erektil dysfunktion (77- 87%), kombineret erektil dysfunktion, (69- 83%), organisk erektil dysfunktion (64- 75%), ældre (52- 75%), iskæmisk hjertesygdom (70- 73%) hyperlipædemi (62- 73%), kronisk lungesygdom (74- 78%) depression (59- 69%) og patienter som samtidigt blev behandlet med antihypertensiva (62- 73%).
In pooled data from the major efficacy trials, the proportion of patients experiencing successful penetration on vardenafil were as follows: psychogenic erectile dysfunction (77-87%), mixed erectile dysfunction (69-83%), organic erectile dysfunction (64-75%), elderly (52-75%), ischaemic heart disease (70-73%), hyperlipidemia (62-73%), chronic pulmonary disease (74-78%), depression (59-69%), and patients concomitantly treated with antihypertensives (62-73%).